在美国一般人口中,CLivD评分改变了FIB-4在肝纤维化检测中的表现
Fredrik Åberg1, Mitja Lääperi1, Ville Männistö2,3
1Transplantation and Liver Surgery, HUS Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
eGastroenterology
|February 13, 2025
概括
慢性肝病 (CLivD) 风险评分可以有效地识别肝硬化和晚期纤维化. 将CLivD与FIB-4结合起来可以提高检测准确度,优化基于人口的肝纤维化查和资源分配.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
- 诊断的准确性 诊断的准确性
背景情况:
- 脂肪性肝病 (SLD) 是一个日益严重的全球健康问题.
- 慢性肝病 (CLivD) 风险评分利用可访问的变量来预测与肝脏相关的结果.
- 评估CLivD与肝硬化症和纤维化症的关联对于早期检测至关重要.
研究的目的:
- 为了评估慢性肝病 (CLivD) 风险评分与肝硬化症和纤维化症的相关性.
- 评估CLivD和FIB-4 (纤维化-4) 的联合性能,以检测晚期肝纤维化.
- 探索CLivD在优化基于人口的肝纤维化查中的实用性.
主要方法:
- 在国家健康和营养检查调查 (2017-2020) 中,利用了3603名参与者 (年龄在40-70岁) 的数据,并使用了有效的肝硬度测量 (LSMs).
- 定义高级纤维化为LSM ≥12 kPa和SLD作为控制的减弱参数≥288 dB/m.
- 将CLivD (实验室和非实验室版本) 和FIB-4用于晚期纤维化检测的诊断性能进行比较.
主要成果:
- CLivD评分显示了与SLD和晚期纤维化有显著的关联.
- 在CLivD实验室 (AUC 0.72) 和CLivD非实验室 (AUC 0.68) 中,对于晚期纤维化比FIB-4 (AUC 0.66) 的准确性更高.
- 一个顺序的CLivD→FIB-4策略提高了特异性 (83%),并确定了一个高流行率的子组,减少了不必要的FIB-4测试.
结论:
- 在一般人群中,CLivD得分可以有效地识别肝硬化和晚期纤维化.
- 将CLivD与FIB-4结合起来,可以提高先进纤维化检测的准确性.
- CLivD可以优化基于人口的肝纤维化查和资源分配.
相关概念视频
Clot Retraction and Fibrinolysis
6.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.1K
Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Ultrasound II: Endoscopic Ultrasound and FibroScan
1.3K
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
1.3K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
274
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
976
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
976
Cirrhosis II: Pathophysiology
49
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
49


